$HBIO SEC Filings

Filed On	Filing
22 Sep 2026	SCHEDULE 13G/A
11 Aug 2026	FORM 10-Q
11 Aug 2026	8-K: Regulation FD Disclosure
11 Aug 2026	8-K: Results of Operations and Financial Condition
12 Jun 2026	Form 4: Eade Katherine A., Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Snider William, Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Denelsky Stephen J, Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Gagnon Robert E., Director Received 16,556 shares as a grant or award
11 Jun 2026	Form 4: Benson Seth Benjamin, Director Received 16,556 shares as a grant or award
10 Jun 2026	FORM S-8
02 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
27 May 2026	FORM SD
14 May 2026	SCHEDULE 13G/A
12 May 2026	FORM 10-Q
12 May 2026	8-K: Results of Operations and Financial Condition
12 May 2026	8-K: Regulation FD Disclosure
21 Apr 2026	FORM DEFA14A
21 Apr 2026	Proxy statement: annual meeting on June 2, 2026 CEO pay $905K · say-on-pay vote
01 Apr 2026	Form 4: Frost Mark T, Chief Financial Officer Received 30,000 shares as a grant or award
01 Apr 2026	Form 4: Frost Mark T, Chief Financial Officer Bought 5,000 shares ($25K)

Comments